 | • レポートコード：D0GIR-03234 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：化学、材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、医療生物医学材料3.0の世界市場を広く調査・分析し、今後の市場展望をまとめております。医療生物医学材料3.0の種類別市場規模（PLA、PGA、PLGA、PLCG、その他）、用途別市場規模（縫合、骨折固定、口腔インプラント、ドラッグデリバリーミクロスフェア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Mitsui Chemicals、Evonik Health Care、PCAS、DURECT、Fujifilm、Lattice Medical、Corbion、Nomisma Healthcare、Phosphorex Inc.、Jinan Daigang Biomaterial、Shenzhen Polymtek Biomaterial Co., Ltd.、Changchun Foliaplast Bio-tech Co., Ltd ・地域別グローバル市場分析 2015年-2020年 ・医療生物医学材料3.0の北米市場（アメリカ、カナダ、メキシコ） ・医療生物医学材料3.0のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・医療生物医学材料3.0のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・医療生物医学材料3.0の南米市場（ブラジル、アルゼンチン） ・医療生物医学材料3.0の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：PLA、PGA、PLGA、PLCG、その他 ・用途別分析：縫合、骨折固定、口腔インプラント、ドラッグデリバリーミクロスフェア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Medical Biomedical Materials 3.0 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Medical Biomedical Materials 3.0 sales will be xx in 2020 from Medical Biomedical Materials 3.0 million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Medical Biomedical Materials 3.0 market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Medical Biomedical Materials 3.0 industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Medical Biomedical Materials 3.0 and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Medical Biomedical Materials 3.0 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Medical Biomedical Materials 3.0 market has been segmented into
PLA
PGA
PLGA
PLCG
Other
By Application, Medical Biomedical Materials 3.0 has been segmented into:
Suture
Fracture Fixation
Oral Implant
Drug Delivery Microsphere
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Medical Biomedical Materials 3.0 market presented in the report. This section sheds light on the sales growth of different regional and country-level Medical Biomedical Materials 3.0 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Medical Biomedical Materials 3.0 market.
The report offers in-depth assessment of the growth and other aspects of the Medical Biomedical Materials 3.0 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Medical Biomedical Materials 3.0 Market Share Analysis
Medical Biomedical Materials 3.0 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Medical Biomedical Materials 3.0 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Medical Biomedical Materials 3.0 sales, revenue and market share for each player covered in this report.
The major players covered in Medical Biomedical Materials 3.0 are:
Merck
Mitsui Chemicals
Evonik Health Care
PCAS
DURECT
Fujifilm
Lattice Medical
Corbion
Nomisma Healthcare
Phosphorex Inc.
Jinan Daigang Biomaterial
Shenzhen Polymtek Biomaterial Co., Ltd.
Changchun Foliaplast Bio-tech Co., Ltd
Among other players domestic and global, Medical Biomedical Materials 3.0 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Biomedical Materials 3.0 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medical Biomedical Materials 3.0, with price, sales, revenue and global market share of Medical Biomedical Materials 3.0 in 2018 and 2019.
Chapter 3, the Medical Biomedical Materials 3.0 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Biomedical Materials 3.0 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Medical Biomedical Materials 3.0 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Medical Biomedical Materials 3.0 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Medical Biomedical Materials 3.0 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medical Biomedical Materials 3.0 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 PLA
1.2.3 PGA
1.2.4 PLGA
1.2.5 PLCG
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Medical Biomedical Materials 3.0 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Suture
1.3.3 Fracture Fixation
1.3.4 Oral Implant
1.3.5 Drug Delivery Microsphere
1.3.6 Others
1.4 Overview of Global Medical Biomedical Materials 3.0 Market
1.4.1 Global Medical Biomedical Materials 3.0 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Medical Biomedical Materials 3.0 Industry Impact
1.6.1 COVID-19 Potential Implications for the Medical Biomedical Materials 3.0
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Medical Biomedical Materials 3.0
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mitsui Chemicals
2.2.1 Mitsui Chemicals Details
2.2.2 Mitsui Chemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mitsui Chemicals SWOT Analysis
2.2.4 Mitsui Chemicals Product and Services
2.2.5 Mitsui Chemicals Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Evonik Health Care
2.3.1 Evonik Health Care Details
2.3.2 Evonik Health Care Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Evonik Health Care SWOT Analysis
2.3.4 Evonik Health Care Product and Services
2.3.5 Evonik Health Care Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 PCAS
2.4.1 PCAS Details
2.4.2 PCAS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 PCAS SWOT Analysis
2.4.4 PCAS Product and Services
2.4.5 PCAS Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 DURECT
2.5.1 DURECT Details
2.5.2 DURECT Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DURECT SWOT Analysis
2.5.4 DURECT Product and Services
2.5.5 DURECT Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Fujifilm
2.6.1 Fujifilm Details
2.6.2 Fujifilm Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Fujifilm SWOT Analysis
2.6.4 Fujifilm Product and Services
2.6.5 Fujifilm Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lattice Medical
2.7.1 Lattice Medical Details
2.7.2 Lattice Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lattice Medical SWOT Analysis
2.7.4 Lattice Medical Product and Services
2.7.5 Lattice Medical Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Corbion
2.8.1 Corbion Details
2.8.2 Corbion Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Corbion SWOT Analysis
2.8.4 Corbion Product and Services
2.8.5 Corbion Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Nomisma Healthcare
2.9.1 Nomisma Healthcare Details
2.9.2 Nomisma Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Nomisma Healthcare SWOT Analysis
2.9.4 Nomisma Healthcare Product and Services
2.9.5 Nomisma Healthcare Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Phosphorex Inc.
2.10.1 Phosphorex Inc. Details
2.10.2 Phosphorex Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Phosphorex Inc. SWOT Analysis
2.10.4 Phosphorex Inc. Product and Services
2.10.5 Phosphorex Inc. Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Jinan Daigang Biomaterial
2.11.1 Jinan Daigang Biomaterial Details
2.11.2 Jinan Daigang Biomaterial Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Jinan Daigang Biomaterial SWOT Analysis
2.11.4 Jinan Daigang Biomaterial Product and Services
2.11.5 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Shenzhen Polymtek Biomaterial Co., Ltd.
2.12.1 Shenzhen Polymtek Biomaterial Co., Ltd. Details
2.12.2 Shenzhen Polymtek Biomaterial Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Shenzhen Polymtek Biomaterial Co., Ltd. SWOT Analysis
2.12.4 Shenzhen Polymtek Biomaterial Co., Ltd. Product and Services
2.12.5 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Changchun Foliaplast Bio-tech Co., Ltd
2.13.1 Changchun Foliaplast Bio-tech Co., Ltd Details
2.13.2 Changchun Foliaplast Bio-tech Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Changchun Foliaplast Bio-tech Co., Ltd SWOT Analysis
2.13.4 Changchun Foliaplast Bio-tech Co., Ltd Product and Services
2.13.5 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Medical Biomedical Materials 3.0 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Medical Biomedical Materials 3.0 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Medical Biomedical Materials 3.0 Manufacturer Market Share in 2019
3.3.2 Top 6 Medical Biomedical Materials 3.0 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Medical Biomedical Materials 3.0 Sales, Revenue and Market Share by Regions
4.1.1 Global Medical Biomedical Materials 3.0 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Medical Biomedical Materials 3.0 Revenue and Market Share by Regions (2015-2020)
4.2 North America Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
4.3 Europe Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
4.5 South America Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Medical Biomedical Materials 3.0 Sales, Revenue and Market Share by Country
5.1.1 North America Medical Biomedical Materials 3.0 Sales and Market Share by Country (2015-2020)
5.1.2 North America Medical Biomedical Materials 3.0 Revenue and Market Share by Country (2015-2020)
5.2 United States Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
5.3 Canada Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
5.4 Mexico Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Medical Biomedical Materials 3.0 Sales, Revenue and Market Share by Country
6.1.1 Europe Medical Biomedical Materials 3.0 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Medical Biomedical Materials 3.0 Revenue and Market Share by Country (2015-2020)
6.2 Germany Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
6.3 UK Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
6.4 France Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
6.5 Russia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
6.6 Italy Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Medical Biomedical Materials 3.0 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Medical Biomedical Materials 3.0 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Medical Biomedical Materials 3.0 Revenue and Market Share by Regions (2015-2020)
7.2 China Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
7.3 Japan Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
7.4 Korea Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
7.5 India Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
7.7 Australia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Medical Biomedical Materials 3.0 Sales, Revenue and Market Share by Country
8.1.1 South America Medical Biomedical Materials 3.0 Sales and Market Share by Country (2015-2020)
8.1.2 South America Medical Biomedical Materials 3.0 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
8.3 Argentina Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Medical Biomedical Materials 3.0 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
9.3 Turkey Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
9.4 Egypt Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
9.5 South Africa Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Medical Biomedical Materials 3.0 Sales and Market Share by Type (2015-2020)
10.2 Global Medical Biomedical Materials 3.0 Revenue and Market Share by Type (2015-2020)
10.3 Global Medical Biomedical Materials 3.0 Price by Type (2015-2020)
11 Global Medical Biomedical Materials 3.0 Market Segment by Application
11.1 Global Medical Biomedical Materials 3.0 Sales Market Share by Application (2015-2020)
11.2 Global Medical Biomedical Materials 3.0 Revenue Market Share by Application (2015-2020)
11.3 Global Medical Biomedical Materials 3.0 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Medical Biomedical Materials 3.0 Sales, Revenue and Growth Rate (2021-2025)
12.2 Medical Biomedical Materials 3.0 Market Forecast by Regions (2021-2025)
12.2.1 North America Medical Biomedical Materials 3.0 Market Forecast (2021-2025)
12.2.2 Europe Medical Biomedical Materials 3.0 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Medical Biomedical Materials 3.0 Market Forecast (2021-2025)
12.2.4 South America Medical Biomedical Materials 3.0 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Medical Biomedical Materials 3.0 Market Forecast (2021-2025)
12.3 Medical Biomedical Materials 3.0 Market Forecast by Type (2021-2025)
12.3.1 Global Medical Biomedical Materials 3.0 Sales Forecast by Type (2021-2025)
12.3.2 Global Medical Biomedical Materials 3.0 Market Share Forecast by Type (2021-2025)
12.4 Medical Biomedical Materials 3.0 Market Forecast by Application (2021-2025)
12.4.1 Global Medical Biomedical Materials 3.0 Sales Forecast by Application (2021-2025)
12.4.2 Global Medical Biomedical Materials 3.0 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Medical Biomedical Materials 3.0 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Medical Biomedical Materials 3.0 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Medical Biomedical Materials 3.0 Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Medical Biomedical Materials 3.0 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Medical Biomedical Materials 3.0 Major Business
Table 10. Merck Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 11. Merck SWOT Analysis
Table 12. Merck Medical Biomedical Materials 3.0 Product and Services
Table 13. Merck Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 15. Mitsui Chemicals Medical Biomedical Materials 3.0 Major Business
Table 16. Mitsui Chemicals Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 17. Mitsui Chemicals SWOT Analysis
Table 18. Mitsui Chemicals Medical Biomedical Materials 3.0 Product and Services
Table 19. Mitsui Chemicals Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Evonik Health Care Basic Information, Manufacturing Base and Competitors
Table 21. Evonik Health Care Medical Biomedical Materials 3.0 Major Business
Table 22. Evonik Health Care Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 23. Evonik Health Care SWOT Analysis
Table 24. Evonik Health Care Medical Biomedical Materials 3.0 Product and Services
Table 25. Evonik Health Care Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. PCAS Basic Information, Manufacturing Base and Competitors
Table 27. PCAS Medical Biomedical Materials 3.0 Major Business
Table 28. PCAS Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 29. PCAS SWOT Analysis
Table 30. PCAS Medical Biomedical Materials 3.0 Product and Services
Table 31. PCAS Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. DURECT Basic Information, Manufacturing Base and Competitors
Table 33. DURECT Medical Biomedical Materials 3.0 Major Business
Table 34. DURECT Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 35. DURECT SWOT Analysis
Table 36. DURECT Medical Biomedical Materials 3.0 Product and Services
Table 37. DURECT Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 39. Fujifilm Medical Biomedical Materials 3.0 Major Business
Table 40. Fujifilm Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 41. Fujifilm SWOT Analysis
Table 42. Fujifilm Medical Biomedical Materials 3.0 Product and Services
Table 43. Fujifilm Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Lattice Medical Basic Information, Manufacturing Base and Competitors
Table 45. Lattice Medical Medical Biomedical Materials 3.0 Major Business
Table 46. Lattice Medical Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 47. Lattice Medical SWOT Analysis
Table 48. Lattice Medical Medical Biomedical Materials 3.0 Product and Services
Table 49. Lattice Medical Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Corbion Basic Information, Manufacturing Base and Competitors
Table 51. Corbion Medical Biomedical Materials 3.0 Major Business
Table 52. Corbion Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 53. Corbion SWOT Analysis
Table 54. Corbion Medical Biomedical Materials 3.0 Product and Services
Table 55. Corbion Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Nomisma Healthcare Basic Information, Manufacturing Base and Competitors
Table 57. Nomisma Healthcare Medical Biomedical Materials 3.0 Major Business
Table 58. Nomisma Healthcare Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 59. Nomisma Healthcare SWOT Analysis
Table 60. Nomisma Healthcare Medical Biomedical Materials 3.0 Product and Services
Table 61. Nomisma Healthcare Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Phosphorex Inc. Basic Information, Manufacturing Base and Competitors
Table 63. Phosphorex Inc. Medical Biomedical Materials 3.0 Major Business
Table 64. Phosphorex Inc. Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 65. Phosphorex Inc. SWOT Analysis
Table 66. Phosphorex Inc. Medical Biomedical Materials 3.0 Product and Services
Table 67. Phosphorex Inc. Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Jinan Daigang Biomaterial Basic Information, Manufacturing Base and Competitors
Table 69. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Major Business
Table 70. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 71. Jinan Daigang Biomaterial SWOT Analysis
Table 72. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Product and Services
Table 73. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Shenzhen Polymtek Biomaterial Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 75. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Major Business
Table 76. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 77. Shenzhen Polymtek Biomaterial Co., Ltd. SWOT Analysis
Table 78. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Product and Services
Table 79. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Changchun Foliaplast Bio-tech Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 81. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Major Business
Table 82. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Total Revenue (USD Million) (2018-2019)
Table 83. Changchun Foliaplast Bio-tech Co., Ltd SWOT Analysis
Table 84. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Product and Services
Table 85. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Medical Biomedical Materials 3.0 Sales by Manufacturer (2018-2019) (Ton)
Table 87. Global Medical Biomedical Materials 3.0 Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Medical Biomedical Materials 3.0 Sales by Regions (2015-2020) (Ton)
Table 89. Global Medical Biomedical Materials 3.0 Sales Market Share by Regions (2015-2020)
Table 90. Global Medical Biomedical Materials 3.0 Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Medical Biomedical Materials 3.0 Sales by Countries (2015-2020) (Ton)
Table 92. North America Medical Biomedical Materials 3.0 Sales Market Share by Countries (2015-2020)
Table 93. North America Medical Biomedical Materials 3.0 Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Medical Biomedical Materials 3.0 Revenue Market Share by Countries (2015-2020)
Table 95. Europe Medical Biomedical Materials 3.0 Sales by Countries (2015-2020) (Ton)
Table 96. Europe Medical Biomedical Materials 3.0 Sales Market Share by Countries (2015-2020)
Table 97. Europe Medical Biomedical Materials 3.0 Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Regions (2015-2020) (Ton)
Table 99. Asia-Pacific Medical Biomedical Materials 3.0 Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Medical Biomedical Materials 3.0 Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Medical Biomedical Materials 3.0 Sales by Countries (2015-2020) (Ton)
Table 102. South America Medical Biomedical Materials 3.0 Sales Market Share by Countries (2015-2020)
Table 103. South America Medical Biomedical Materials 3.0 Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Medical Biomedical Materials 3.0 Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Countries (2015-2020) (Ton)
Table 106. Middle East & Africa Medical Biomedical Materials 3.0 Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Medical Biomedical Materials 3.0 Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Medical Biomedical Materials 3.0 Revenue Market Share by Countries (2015-2020)
Table 109. Global Medical Biomedical Materials 3.0 Sales by Type (2015-2020) (Ton)
Table 110. Global Medical Biomedical Materials 3.0 Sales Share by Type (2015-2020)
Table 111. Global Medical Biomedical Materials 3.0 Revenue by Type (2015-2020) (USD Million)
Table 112. Global Medical Biomedical Materials 3.0 Revenue Share by Type (2015-2020)
Table 113. Global Medical Biomedical Materials 3.0 Sales by Application (2015-2020) (Ton)
Table 114. Global Medical Biomedical Materials 3.0 Sales Share by Application (2015-2020)
Table 115. Global Medical Biomedical Materials 3.0 Sales Forecast by Regions (2021-2025) (Ton)
Table 116. Global Medical Biomedical Materials 3.0 Market Share Forecast by Regions (2021-2025)
Table 117. Global Medical Biomedical Materials 3.0 Sales Forecast by Type (2021-2025) (Ton)
Table 118. Global Medical Biomedical Materials 3.0 Market Share Forecast by Type (2021-2025)
Table 119. Global Medical Biomedical Materials 3.0 Sales Forecast by Application (2021-2025)
Table 120. Global Medical Biomedical Materials 3.0 Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Medical Biomedical Materials 3.0 Picture
Figure 2. Global Sales Market Share of Medical Biomedical Materials 3.0 by Type in 2019
Figure 3. PLA Picture
Figure 4. PGA Picture
Figure 5. PLGA Picture
Figure 6. PLCG Picture
Figure 7. Other Picture
Figure 8. Medical Biomedical Materials 3.0 Sales Market Share by Application in 2018
Figure 9. Suture Picture
Figure 10. Fracture Fixation Picture
Figure 11. Oral Implant Picture
Figure 12. Drug Delivery Microsphere Picture
Figure 13. Others Picture
Figure 14. Global Medical Biomedical Materials 3.0 Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Medical Biomedical Materials 3.0 Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Medical Biomedical Materials 3.0 Sales Market Share by Manufacturer in 2019
Figure 35. Global Medical Biomedical Materials 3.0 Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Medical Biomedical Materials 3.0 Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Medical Biomedical Materials 3.0 Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 40. Global Medical Biomedical Materials 3.0 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Medical Biomedical Materials 3.0 Revenue Market Share by Regions (2015-2020)
Figure 42. Global Medical Biomedical Materials 3.0 Revenue Market Share by Regions in 2018
Figure 43. North America Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
Figure 44. Europe Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
Figure 46. South America Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020)
Figure 48. North America Medical Biomedical Materials 3.0 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Medical Biomedical Materials 3.0 Sales Market Share by Countries (2015-2020)
Figure 50. North America Medical Biomedical Materials 3.0 Sales Market Share by Countries in 2018
Figure 51. North America Medical Biomedical Materials 3.0 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Medical Biomedical Materials 3.0 Revenue Market Share by Countries in 2018
Figure 53. United States Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 54. Canada Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 55. Mexico Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 56. Europe Medical Biomedical Materials 3.0 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Medical Biomedical Materials 3.0 Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Medical Biomedical Materials 3.0 Revenue Market Share by Countries in 2019
Figure 59. Germany Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 60. UK Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 61. France Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 62. Russia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 63. Italy Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 64. Asia-Pacific Medical Biomedical Materials 3.0 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Medical Biomedical Materials 3.0 Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Medical Biomedical Materials 3.0 Revenue Market Share by Regions 2019
Figure 67. China Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 68. Japan Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 69. Korea Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 70. India Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 71. Southeast Asia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 72. South America Medical Biomedical Materials 3.0 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Medical Biomedical Materials 3.0 Sales Market Share by Countries in 2019
Figure 74. South America Medical Biomedical Materials 3.0 Revenue Market Share by Countries in 2019
Figure 75. Brazil Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 76. Argentina Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 77. Middle East and Africa Medical Biomedical Materials 3.0 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Medical Biomedical Materials 3.0 Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Medical Biomedical Materials 3.0 Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Medical Biomedical Materials 3.0 Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 82. Egypt Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 83. Turkey Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 84. South Africa Medical Biomedical Materials 3.0 Sales and Growth Rate (2015-2020) (Ton)
Figure 85. Global Medical Biomedical Materials 3.0 Sales and Growth Rate (2021-2025) (Ton)
Figure 86. Global Medical Biomedical Materials 3.0 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Medical Biomedical Materials 3.0 Market Forecast (2021-2025) (Ton)
Figure 88. Europe Sales Medical Biomedical Materials 3.0 Market Forecast (2021-2025) (Ton)
Figure 89. Asia-Pacific Sales Medical Biomedical Materials 3.0 Market Forecast (2021-2025) (Ton)
Figure 90. South America Sales Medical Biomedical Materials 3.0 Market Forecast (2021-2025) (Ton)
Figure 91. Middle East & Africa Sales Medical Biomedical Materials 3.0 Market Forecast (2021-2025) (Ton)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
ポリ（L-ラクチド-コ-グリコリド）（PLCG）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Poly(L-lactide-co-glycolide) (PLCG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- 医療用インプラント抗菌コーティングの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Medical Implant Antibacterial Coating market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- コラーゲン繊維縫合の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Collagen Fiber Suture market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Collagen Fiber Suture m…
- 生物医学センサーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biomedical Sensors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9929.4 million by 2025, from USD 8854.1 million in 2019. The Biomedical Sensor…
- 生物医学温度センサーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biomedical Temperature Sensors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 6110.4 million by 2025, from USD 5286 million in 2019. The Biomedi…